Free Trial

Genprex (GNPX) News Today

Genprex logo
$1.18 +0.08 (+6.82%)
(As of 02:08 PM ET)
Genprex signs exclusive license agreement with University of Michigan
Genprex to Participate in 2024 BIO Europe Conference
Looking Into Genprex's Recent Short Interest
Genprex advances dose in lung cancer trial
Genprex, Inc. (GNPX) interactive stock chart – Yahoo Finance
S&P 500 Gains 1%; Home Depot Earnings Top Views
Genprex Appoints Toscano As Chairman
Get Genprex News Delivered to You Automatically

Sign up to receive the latest news and ratings for GNPX and its competitors with MarketBeat's FREE daily newsletter.

“This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!

GNPX Media Mentions By Week

GNPX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GNPX
News Sentiment

1.38

0.47

Average
Medical
News Sentiment

GNPX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GNPX Articles
This Week

3

1

GNPX Articles
Average Week

Get Genprex News Delivered to You Automatically

Sign up to receive the latest news and ratings for GNPX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:GNPX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners